BioVersys

Series C

Basel, SwitzerlandJun 2022

BioVersys raised €23M in a Series C round in Jun 2022. The company is based in Basel, Switzerland. Data as of Nov 2026.

Amount raised

€23M

€23,078,390

Native amount

24,200,000 CHF

Stage

Series C

series c

Investors

Provenance & confidence

High confidence

Amount

24,200,000 CHF

ECB-at-date → €23M · rate 1.0486 on 2022-06-08

High confidence

Source

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

0 named

No investors disclosed for this round.

Date

Jun 2022

Round type

series c

Amount (EUR)

€23M

same company